BYONG (CHRISTOPHER) KIM

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LIPELLA PHARMACEUTICALS INC.

Filing Date Source Excerpt
2023-10-10 Mr. Kim holds a B.S. in Biology from the University of California at Irvine, a PhD in Developmental Biology from the University of Texas at MD Anderson, and an MBA from Carnegie Mellon University.
2024-08-12 Mr. Kim holds a B.S. in Biology from the University of California at Irvine, a PhD in Developmental Biology from the University of Texas at MD Anderson, and an MBA from Carnegie Mellon University.
2024-11-12 Byong (Christopher) Kim beneficially owns shares and holds stock options exercisable for shares of Common Stock, but no mention of software or technical background.

Data sourced from SEC filings. Last updated: 2026-03-09